The abstract is read at the publisher; the summary is JClub's.
Elevated purines, especially deoxyguanosine (dG), suppress mTORC1 signaling by reducing RHEB activity through a TUFM-dependent control of RHEB nucleotide binding.
- Why it matters: Purine metabolite buildup is seen in disease and therapy, but how it reshapes core growth signaling pathways like mTORC1 is not well defined.
- What they did: Using gain-of-function PRPS1 mutations to model intracellular purine accumulation, the study mapped how dG alters RHEB phosphorylation and TUFM association, and tested a second purine-buildup condition via xanthine dehydrogenase/oxidase inhibition.
- The result: dG increased RHEB phosphorylation at Ser130, promoting TUFM and guanine nucleotide dissociation from RHEB and lowering downstream mTORC1 signaling; similar effects occurred with xanthine dehydrogenase/oxidase inhibition, supporting a TUFM-RHEB regulatory link.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.